Enhancing the Government of Indiaкs Capacity through PEPFAR to Scale Up and Improve Comprehensive HIV Service Package Quality for People Who Inject Drugs under the President's Emergency Plan for AIDS Relief (PEPFAR)

Post Date

August 28th 2014

Application Due Date

October 15th 2014

Funding Opportunity Number

CDC-RFA-GH15-1542

CFDA Number(s)

93.067

Funding Instrument Type(s)

Cooperative Agreement

Funding Activity Categories

Health

Number of Awards

1

Eligibility Categories

Other

Eligible applicants that can apply for this FOA are listed below: Government Organizations: ╔ National Ministries of Health ╔ State and local governments or their Bona Fide Agents (this includes the District of Columbia, the Commonwealth of Puerto Rico, the Virgin Islands, the Commonwealth of the Northern Marianna Islands, American Samoa, Guam, the Federated States of Micronesia, the Republic of the Marshall Islands, and the Republic of Palau) . ╔ American Indian/Alaska Native tribal governments (federally recognized or state-recognized) ╔ Political subdivisions of States (in consultation with States) Non-government Organizations: ╔ American Indian/Alaska native tribally designated organizations ╔ Alaska Native health corporations ╔ Tribal epidemiology centers ╔ Urban Indian health organizations ╔ Nonprofit with 501C3 IRS status (other than institution of higher education) ╔ Nonprofit without 501C3 IRS status (other than institution of higher education) ╔ Research institutions (that will perform activities deemed as non-research) Colleges and Universities Community-based organizations Faith-based organizations For-profit organizations (other than small business) Hospitals Small, minority, and women-owned businesses All Other eligible organizations

Funding

• Estimated Total Funding:

  $0

• Award Range:

  $0 - $1800000

Grant Description

Despite the scale up of interventions among People Who Inject Drugs (PWID), HIV prevalence continues to be high in India at 7.1%. Most worrisome is the continued high HIV prevalence in the North Eastern states (NE) of Manipur (12.9%), Mizoram (12.0%) and Meghalaya (6.4%). A qualitative study (2011) carried out to assess gaps in the national PWID program revealed that PWID interventions in India and especially NE states where the epidemic lies are lagging in terms of intensity and coverage of interventions, continued barriers to accessing services, stigma and discrimination, and lack of skills in dealing with PWID among service providers. Another observation by the qualitative study is that most PWIDs have transitioned from non-injecting modes of administration (e.g., smoking or chasing heroin) to injecting (e.g., injecting pharmaceuticals or heroin). Analysis of national program data revealed that Opioid Substitution Therapy (OST) coverage in NE states was 12% (planned target 20%) and retention was also low (59%). Similarly, HIV testing coverage was also low (48%) in NE states. There is scant information on the extent of female PWID and the challenges this group faces accessing services. The estimated number of female PWID is 10,000 and they are concentrated in NE states. HIV testing facility data reveals a prevalence of 7-25% among female PWID. Similarly, HIV prevalence has been reported to be high among spouses of PWID (2.5% to 5%). There are also concerns regarding high reported spousal violence among this population (55%).

Contact Information

• Agency

  Department of Health and Human Services

• Office:

  Centers for Disease Control and Prevention

• Agency Contact:

  CDC Procurement and Grants Office
  Technical Information Management Section
  E-mail: pgotim@cdc.gov
  Phone: 770-488-2700
  

• Agency Mailing Address:

  PGO TIM

• Agency Email Address:

  pgotim@cdc.gov